Healthcare provider profile · identity verified

Scott Menard, MD

General Practice · MOUNT DORA, FL · NPI 1417579244

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	248	94
Rosuvastatin Calcium	Rosuvastatin Calcium	226	109
Meloxicam	Meloxicam	212	71
Alprazolam	Alprazolam	166	44
Amlodipine Besylate	Amlodipine Besylate	149	70
Metformin Hcl	Metformin Hcl	138	56
Tramadol Hcl	Tramadol Hcl	138	43
Lisinopril	Lisinopril	131	60
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	129	35
Losartan Potassium	Losartan Potassium	119	63
Levothyroxine Sodium	Levothyroxine Sodium	118	47
Trazodone Hcl	Trazodone Hcl	118	52
Atorvastatin Calcium	Atorvastatin Calcium	111	56
Metoprolol Tartrate	Metoprolol Tartrate	110	43
Pantoprazole Sodium	Pantoprazole Sodium	106	52
Albuterol Sulfate Hfa	Albuterol Sulfate	96	40
Acetaminophen-Codeine	Acetaminophen With Codeine	83	33
Tamsulosin Hcl	Tamsulosin Hcl	80	33
Furosemide	Furosemide	71	25
Clonazepam	Clonazepam	69	16
Baclofen	Baclofen	68	34
Eliquis	Apixaban	68	26
Ibuprofen	Ibuprofen	65	35
Prednisone	Prednisone	65	41
Omeprazole	Omeprazole	63	32
Metoprolol Succinate	Metoprolol Succinate	62	28
Azithromycin	Azithromycin	55	53
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	54	24
Triamcinolone Acetonide	Triamcinolone Acetonide	52	32
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	51	suppressed
Fenofibrate	Fenofibrate	51	23
Ondansetron Hcl	Ondansetron Hcl	48	19
Pravastatin Sodium	Pravastatin Sodium	48	24
Clopidogrel	Clopidogrel Bisulfate	47	29
Farxiga	Dapagliflozin Propanediol	47	19
Hydrochlorothiazide	Hydrochlorothiazide	46	22
Metformin Hcl Er	Metformin Hcl	44	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	43	20
Pregabalin	Pregabalin	43	16
Zolpidem Tartrate	Zolpidem Tartrate	42	14
Allopurinol	Allopurinol	41	17
Clonidine Hcl	Clonidine Hcl	41	17
Duloxetine Hcl	Duloxetine Hcl	41	18
Jardiance	Empagliflozin	41	11
Carvedilol	Carvedilol	39	18
Escitalopram Oxalate	Escitalopram Oxalate	39	18
Hydroxyzine Hcl	Hydroxyzine Hcl	39	23
Hydralazine Hcl	Hydralazine Hcl	37	20
Ozempic	Semaglutide	37	12
Quetiapine Fumarate	Quetiapine Fumarate	37	12
Symbicort	Budesonide/Formoterol Fumarate	37	suppressed
Tizanidine Hcl	Tizanidine Hcl	37	13
Methotrexate	Methotrexate Sodium	35	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	33	suppressed
Celecoxib	Celecoxib	33	13
Fluticasone Propionate	Fluticasone Propionate	33	15
Memantine Hcl	Memantine Hcl	33	16
Ezetimibe	Ezetimibe	32	15
Glipizide	Glipizide	32	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	32	suppressed
Propranolol Hcl	Propranolol Hcl	31	suppressed
Buspirone Hcl	Buspirone Hcl	30	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	30	14
Simvastatin	Simvastatin	30	12
Vitamin D2	Ergocalciferol (Vitamin D2)	30	17
Trulicity	Dulaglutide	29	14
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Methocarbamol	Methocarbamol	28	14
Montelukast Sodium	Montelukast Sodium	28	17
Testosterone Cypionate	Testosterone Cypionate	28	13
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	27	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	27	13
Alendronate Sodium	Alendronate Sodium	26	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	22
Sertraline Hcl	Sertraline Hcl	26	11
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	25	suppressed
Januvia	Sitagliptin Phosphate	24	suppressed
Meclizine Hcl	Meclizine Hcl	24	14
Spironolactone	Spironolactone	24	suppressed
Atenolol	Atenolol	23	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	22	suppressed
Famotidine	Famotidine	22	12
Mresvia	Rsv Vaccine, Pref, Mrna/Pf	22	22
Potassium Chloride	Potassium Chloride	21	12
Aripiprazole	Aripiprazole	20	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	20	suppressed
Glimepiride	Glimepiride	20	11
Linzess	Linaclotide	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Entresto	Sacubitril/Valsartan	19	suppressed
Ketoconazole	Ketoconazole	19	suppressed
Loperamide	Loperamide Hcl	19	suppressed
Terbinafine Hcl	Terbinafine Hcl	19	11
Diclofenac Potassium	Diclofenac Potassium	18	suppressed
Glipizide Er	Glipizide	18	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Acyclovir	Acyclovir	17	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	16	suppressed
Lorazepam	Lorazepam	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Mounjaro	Tirzepatide	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Lanoxin	Digoxin	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Topiramate	Topiramate	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Estradiol	Estradiol	14	suppressed
Fluconazole	Fluconazole	14	12
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Oxcarbazepine	Oxcarbazepine	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Diazepam	Diazepam	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Metronidazole	Metronidazole	12	11
Neomycin-Polymyxin-Hydrocort	Neomycin/Polymyxin B/Hydrocort	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Finasteride	Finasteride	11	suppressed
Haloperidol Decanoate	Haloperidol Decanoate	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error